Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 74 Breast Neoplasms 70 Rectal Neoplasms 51 Stomach Neoplasms 45 Glioblastoma 45 Esophageal Neoplasms 41 Colorectal Neoplasms 37 Lung Neoplasms 35 Brain Neoplasms 35 Squamous Cell Carcinoma of Head and Neck 32 Pancreatic Neoplasms 31 Glioma 27 Neoplasms 26 Sarcoma 23 Neoplasm Metastasis 23 Astrocytoma 22 Head and Neck Neoplasms 21 Carcinoma, Hepatocellular 18 Esophageal Squamous Cell Carcinoma 16 Colonic Neoplasms 16 Recurrence 15 Ovarian Neoplasms 15 Melanoma 15 Gliosarcoma 15 Central Nervous System Neoplasms 15 Urinary Bladder Neoplasms 13 Oligodendroglioma 13 Uterine Cervical Neoplasms 12 Adenocarcinoma Of Esophagus 12 Prostatic Neoplasms 11

Interventions

Anastrozole 8 exemestane 7 Trastuzumab 7 Letrozole 7 palbociclib 6 Docetaxel 6 abemaciclib 5 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 Cyclophosphamide 4 Tamoxifen 3 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Surgical Procedures, Operative × Clear all

NCT00842465 2013-11-25

Prolacsein

Assistance Publique - Hôpitaux de Paris

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡